Rajendran P, Sekar R, Abu Zahra H, Jayaraman S, Rajagopal P, Abdallah B
Noncoding RNA Res. 2023; 8(3):376-384.
PMID: 37250455
PMC: 10220469.
DOI: 10.1016/j.ncrna.2023.05.001.
Zhou J, Wang C, Liu Y, Cui D, Wang Z, Jiang Y
Cancer Cell Int. 2022; 22(1):359.
PMID: 36397164
PMC: 9673286.
DOI: 10.1186/s12935-022-02753-1.
Jiang P, Mao L, Lei X, Luo C, Zhang Y, Zhong X
Am J Cancer Res. 2022; 12(7):3464-3478.
PMID: 35968334
PMC: 9360223.
Satapathy S, Kumar C, Singh R
Cell Med. 2020; 11:2155179019873849.
PMID: 32634196
PMC: 6732848.
DOI: 10.1177/2155179019873849.
Wu B, Li J, Wang H, Wu Q, Liu H
Naunyn Schmiedebergs Arch Pharmacol. 2020; 393(11):2197-2208.
PMID: 32040593
DOI: 10.1007/s00210-020-01834-0.
MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells.
Kim E, Jang J, Sung E, Song I, Kim J, Lee T
Int J Mol Sci. 2019; 20(14).
PMID: 31331056
PMC: 6679220.
DOI: 10.3390/ijms20143540.
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Terbuch A, Adiprasito J, Stiegelbauer V, Seles M, Klec C, Pichler G
Int J Mol Sci. 2018; 19(10).
PMID: 30321995
PMC: 6213366.
DOI: 10.3390/ijms19103130.
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Leao R, Apolonio J, Lee D, Figueiredo A, Tabori U, Castelo-Branco P
J Biomed Sci. 2018; 25(1):22.
PMID: 29526163
PMC: 5846307.
DOI: 10.1186/s12929-018-0422-8.
MicroRNAs and metabolic disorders - where are we heading?.
Sliwinska A, Kasinska M, Drzewoski J
Arch Med Sci. 2017; 13(4):885-896.
PMID: 28721157
PMC: 5507111.
DOI: 10.5114/aoms.2017.65229.
Biomarkers of genome instability and cancer epigenetics.
Reis A, Vargas F, Lemos B
Tumour Biol. 2016; 37(10):13029-13038.
PMID: 27468720
DOI: 10.1007/s13277-016-5278-5.
Relationship between microRNA genes incidence and cancer-associated genomic regions in canine tumors: a comprehensive bioinformatics study.
Zamani-Ahmadmahmudi M
Funct Integr Genomics. 2016; 16(2):143-52.
PMID: 26780769
DOI: 10.1007/s10142-016-0473-4.
MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer.
Li Q, Han Y, Wang C, Shan S, Wang Y, Zhang J
Cancer Cell Int. 2015; 15:84.
PMID: 26388699
PMC: 4573481.
DOI: 10.1186/s12935-015-0233-x.
High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.
Czubak K, Lewandowska M, Klonowska K, Roszkowski K, Kowalewski J, Figlerowicz M
Oncotarget. 2015; 6(27):23399-416.
PMID: 26156018
PMC: 4695126.
DOI: 10.18632/oncotarget.4351.
Challenges and opportunities of microRNAs in lymphomas.
De Tullio G, de Fazio V, Sgherza N, Minoia C, Serrati S, Merchionne F
Molecules. 2014; 19(9):14723-81.
PMID: 25232701
PMC: 6271734.
DOI: 10.3390/molecules190914723.
MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma.
Peng S, Liao C, Peng C, Cheng A, Chen S, Huang C
PLoS One. 2014; 9(7):e102403.
PMID: 25050621
PMC: 4106832.
DOI: 10.1371/journal.pone.0102403.
The role of microRNAs in lung cancer progression.
Zhang W, Liu J, Xu X, Wang G
Med Oncol. 2013; 30(3):675.
PMID: 23925663
DOI: 10.1007/s12032-013-0675-8.
microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics.
Navarro A, Clot G, Prieto M, Royo C, Vegliante M, Amador V
Clin Cancer Res. 2013; 19(12):3121-9.
PMID: 23640973
PMC: 3691513.
DOI: 10.1158/1078-0432.CCR-12-3077.
An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas.
Cirilo P, Marchi F, Barros Filho M, Rocha R, Domingues M, Jurisica I
PLoS One. 2013; 8(3):e57901.
PMID: 23483937
PMC: 3587425.
DOI: 10.1371/journal.pone.0057901.
MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice.
Pan Y, Jia T, Zhang Y, Zhang K, Zhang R, Li J
Int J Nanomedicine. 2012; 7:5957-67.
PMID: 23233803
PMC: 3518289.
DOI: 10.2147/IJN.S37990.
Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging.
Brito J, Gomes C, Santos Pimenta F, Barbosa A, Prado M, Prado V
Exp Ther Med. 2012; 1(1):217-221.
PMID: 23136618
PMC: 3490345.
DOI: 10.3892/etm_00000035.